Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternating monotherapy is the preferred treatment.

N M Kaplan

    Pharmacotherapy
    |July 1, 1985
    PubMed
    Summary

    Initial hypertension therapy choices impact cardiovascular health. Adrenergic inhibitors are preferred over diuretics, with alpha blockers or centrally acting drugs being better first-line options than beta blockers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editor's Mail.

    Postgraduate medicine·2016
    Same author

    Microbiology of wound infection after caesarean section in a Jordanian hospital.

    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2006
    Same author

    What is the impact of systolic blood pressure lowering on preventing cardiovascular events?

    Journal of human hypertension·2004
    Same author

    The place of diuretics in preventing cardiovascular events.

    Journal of human hypertension·2004
    Same author

    Use of thermonuclease testing to identify Staphylococcus aureus by direct examination of blood cultures.

    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2004
    Same author

    Executive summaries on hypertension II. Choices of initial drug therapy.

    Drugs of today (Barcelona, Spain : 1998)·2004

    Area of Science:

    • Cardiology
    • Pharmacology
    • Public Health

    Background:

    • The third Joint National Committee (JNC) report in 1984 recommended changes in hypertension management.
    • These changes included a more conservative approach to drug therapy and broader initial drug choices.
    • Nondrug therapies were also recommended for broader use.

    Purpose of the Study:

    • To evaluate the critical role of initial therapy in reducing cardiovascular morbidity and mortality in hypertensive patients.
    • To advocate for expanded initial therapy choices beyond current recommendations.
    • To express concern regarding the hazards of diuretic therapy.

    Main Methods:

    • Review and critical analysis of the 1984 JNC report recommendations.
    • Clinical judgment and expert opinion on the efficacy and safety of different antihypertensive drug classes.
    • Discussion of potential alternative first-line agents for hypertension management.

    Main Results:

    • The author supports the JNC's move towards more conservative drug initiation and broader choices.
    • Concerns are raised about the potential hazards associated with diuretic therapy.
    • Adrenergic inhibitors are proposed as a preferable first-line drug class for most hypertensive patients.

    Conclusions:

    • Initial antihypertensive therapy selection is crucial for long-term cardiovascular outcomes.
    • Adrenergic inhibitors, specifically alpha blockers or centrally acting agents, may be superior to beta blockers as initial therapy.
    • Calcium antagonists are anticipated to become viable initial treatment options in the future.

    Related Experiment Videos